[1] Mavragani CP, Nezos A, Moutsopoulos HM. New advances in the classification, pathogenesis and treatment of Sjogren's syndrome. Curr Opin Rheumatol, 2013, 25:623-629. [2] Wei W, Ahmad SS, Chi S, et al. From molecular mechanism to the etiology of Sjogren Syndrome. Curr Pharm Des, 2018, 24:4177-4185. [3] Cafaro G, Croia C, Argyropoulou OD, et al. One year in review 2019: Sjogren's syndrome. Clin Exp Rheumatol, 2019, 37 Suppl 118:3-15. [4] Nguyen CQ, Hu MH, Li Y, et al. Salivary gland tissue expression of interleukin-23 and interleukin-17 in Sjogren's syndrome: findings in humans and mice. Arthritis Rheum, 2008, 58:734-743. [5] Ali AH, Carey EJ, Lindor KD. Diagnosis and management of primary biliary cirrhosis. Expert Rev Clin Immunol, 2014, 10:1667-1678. [6] Gonzalez RS, Washington K. Primary Biliary Cholangitis and Autoimmune Hepatitis. Surg Pathol Clin, 2018, 11:329-349. [7] Prince MI, Jones DE. Primary biliary cirrhosis: new perspectives in diagnosis and treatment. Postgrad Med J, 2000, 76:199-206. [8] Kim KA, Jeong SH. The diagnosis and treatment of primary biliary cirrhosis. Korean J Hepatol, 2011, 17:173-179. [9] Selmi C, Invernizzi P, Keeffe EB, et al. Epidemiology and pathogenesis of primary biliary cirrhosis. J Clin Gastroenterol, 2004, 38:264-271. [10] Ge J, Wang K, Meng QH, et al. Implication of Th17 and Th1 cells in patients with chronic active hepatitis B. J Clin Immunol, 2010, 30:60-67. [11] Noack M, Miossec P. Th17 and regulatory T cell balance in autoimmune and inflammatory diseases. Autoimmun Rev, 2014, 13:668-677. [12] Li X, Yuan FL, Lu WG, et al. The role of interleukin-17 in mediating joint destruction in rheumatoid arthritis. Biochem Biophys Res Commun, 2010, 397:131-135. [13] Vignali DA, Collison LW, Workman CJ. How regulatory T cells work. Nat Rev Immunol, 2008, 8:523-532. [14] Afzali B, Lombardi G, Lechler RI, et al. The role of T helper 17 (Th17) and regulatory T cells (Treg) in human organ transplantation and autoimmune disease. Clin Exp Immunol, 2007, 148:32-46. [15] Li MO, Wan YY, Flavell RA. T cell-produced transforming growth factor-beta1 controls T cell tolerance and regulates Th1- and Th17-cell differentiation. Immunity, 2007, 26:579-591. |